Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 15/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | MET | P08581 | 4/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2881998 | 0.86 | ROCK2 (0.75) | ROCK2CYP3A4MET | |
| SCHEMBL8325358 | 0.85 | ROCK2 (0.73) | ROCK2CYP3A4METFLT3 | |
| SCHEMBL13288569 | 0.84 | ROCK2 (0.71) | ROCK2CYP3A4MET | |
| SCHEMBL13288567 | 0.83 | ROCK2 (0.71) | ROCK2CYP3A4METFLT3 | |
| SCHEMBL8324106 | 0.83 | ROCK2 (1.00) | ROCK2CYP3A4MET | |
| SCHEMBL8326061 | 0.83 | ROCK2 (0.82) | ROCK2CYP3A4METFLT3 | |
| SCHEMBL2880048 | 0.82 | ROCK2 (0.69) | ROCK2CYP3A4MET | |
| SCHEMBL8326078 | 0.82 | ROCK2 (0.68) | ROCK2CYP3A4MET | |
| SCHEMBL2877122 | 0.81 | ROCK2 (1.00) | ROCK2CYP3A4METFLT3 | |
| SCHEMBL13288561 | 0.81 | ROCK2 (0.68) | ROCK2CYP3A4METFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737153-B2 | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-06-15 | — | — | US | disclosed |
| US-7737153-B2 | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-06-15 | — | — | US | disclosed |